XIII. 4. Breastfeeding

Breast milk is more than nourishment: its oligosaccharides selectively feed bifidobacteria, and its immune factors guide an infant's early gut and immune development.

More Than Nutrition: A Microbial Inheritance

Breastfeeding is the infant’s primary microbial exposure, shaping the gut ecosystem and immune programming [144].

The microbiota-shaping effects of breastfeeding were illuminated by the discovery of human milk oligosaccharides (HMOs) – the third most abundant solid component of human milk after lactose and fat, and a component that the infant cannot digest. This appeared paradoxical until studies showed that HMOs are selectively fermented by Bifidobacterium longum subsp. infantis, a species that colonizes the infant gut during vaginal delivery and is exquisitely adapted to HMO metabolism through a specific gene cluster (HMO utilization locus) not shared by adult Bifidobacterium species or formula-associated organisms. [84] The consequences of HMO feeding for the infant immune system were characterized by a series of studies showing that Bifidobacterium infantis, grown on HMOs, produces acetate and lactate that acidify the infant gut to pH below 5.5, creating a chemical environment hostile to enteric pathogens. Bifidobacterium infantis also directly interacts with intestinal epithelial cells and immune cells: it induces regulatory T cell (immune cells that suppress excessive immune responses and maintain tolerance) differentiation, reduces inflammatory cytokine production, and supports intestinal barrier maturation in a manner that formula-associated organisms do not replicate. [39] The effects of formula feeding on gut microbiota extend beyond the absence of HMOs. Formula microbiota is more diverse – less Bifidobacterium-dominated – but in a way associated with higher inflammatory markers: formula-fed infants show higher fecal pH, higher Clostridium and Bacteroides abundances, higher fecal endotoxin levels, and higher circulating inflammatory markers than breastfed counterparts in the first 6 months. [24] Extended breastfeeding – beyond 6 months into the second year – has been associated in observational studies with sustained microbiota differences, higher vaccine response, and lower respiratory and GI infection rates. The effects are not explained by socioeconomic confounding alone; mechanistic studies in animals confirm that the HMO-Bifidobacterium-immune axis is a biologically active pathway, not merely a marker of other health behaviors.

Breastfeeding is not only a way to deliver calories. It is also a steady stream of biological signals that influence how the infant gut community forms during a sensitive developmental window. In clinical terms, it helps explain why feeding choices can shape early immune and gut patterns even when growth is otherwise normal [24].

Human milk is not sterile. It contains immune factors, antimicrobial proteins, and small numbers of microorganisms that can be detected with modern methods. What matters most, however, is not simply “milk bacteria,” but the combination of microbial exposure with the milk’s selective nutrients and immune guidance.

A central feature is the presence of human milk oligosaccharides. These complex sugars are not digested by the infant, but they are efficiently used by specific infant-adapted microbes, especially certain Bifidobacterium strains. This creates a nutritional advantage that supports a characteristic early-life pattern: bifidobacterial dominance rather than broad diversity.

This early ecosystem interacts with the gut lining and immune system. Microbial metabolites, including short-chain fatty acids, can support epithelial function and are linked with inflammatory control. In parallel, secretory IgA from milk coats mucosal surfaces and helps shape which microbes persist, offering protection while the infant immune system is still developing its own stable responses.

The origins of microorganisms found in milk are still being clarified. Evidence supports contributions from maternal skin and from infant–mother contact during feeding, and there are also hypotheses about transfer from the maternal gut. The practical takeaway is that milk-related microbial exposure is real, but its sources and relative importance vary between individuals.

When feeding relies mainly on formula, infants can still thrive nutritionally, yet the microbial trajectory often differs. Many studies find less bifidobacterial dominance and a community that appears “more mixed” at an earlier age. This is not automatically harmful, but it represents a different developmental route compared with the typical breastfed pattern.

Milk composition also changes over time. It adapts across weeks and months and can shift with maternal diet and health. For this reason, partial breastfeeding may still provide meaningful immune and ecological signals, even when exclusive breastfeeding is not possible.

Thinking of breastfeeding as microbial inheritance is useful when it stays grounded in biology: milk provides selective nutrients and immune factors that help establish an infant-typical gut community. This foundation does not determine a child’s future on its own, but it can support early immune balance and gut stability during a period when both systems are still being built.

Supporting the Microbiota Through Breastfeeding

Early initiation of breastfeeding is considered helpful because the first feeds provide initial microbial and immunological signals at a moment when the infant gut is especially receptive.

Exclusive breastfeeding during the first months tends to create a bifidobacteria-oriented microbial pattern, which is typical for human infancy rather than aiming for maximal diversity.

The mother’s diet influences milk composition mainly through metabolites and bioactive factors, with fiber-rich and plant-based foods supporting this process.

Maternal well-being, including adequate sleep and stress reduction, is linked with more stable lactation and may indirectly affect microbial components of milk.

When antibiotics are required for the mother, their use is balanced against the fact that they can cause temporary shifts in infant microbiota.

Skin-to-skin contact during feeding provides additional, non-milk microbial exposure from maternal skin and the infant oral cavity.

Routine sterilization of the breast is generally unnecessary; preserving the normal skin environment is regarded as compatible with healthy feeding.

Donor human milk can replace nutritional and immune functions when direct breastfeeding is not possible, although pasteurization reduces viable microbial content.

The role of maternal probiotics is viewed cautiously, as benefits for the infant microbiota are inconsistent and strain-dependent.

Overall maternal nutrition and hydration support milk production, while the microbial effects arise mainly from milk-borne factors and HMOs rather than from diet-derived microbes.

Microbiota Effects

• Breastfeeding promotes Bifidobacterium-dominated gut communities, especially B. infantis adapted to HMOs [84].
• Human milk oligosaccharides act as selective growth factors, not general nutrients for the infant [39].
• Compared with formula feeding, breastfed infants show lower Pseudomonadota (formerly Proteobacteria) and Enterobacteriaceae representation.
• Microbial metabolites such as acetate and butyrate support epithelial tight-junction regulation.
• Milk-derived secretory IgA guides microbial selection and mucosal tolerance.
• The milk ecosystem contains bacteriophages, low-abundance fungi (e.g., Candida), and occasional archaea.
• Maternal diet mainly influences milk metabolites, indirectly shaping infant microbes.
• Maternal antibiotic exposure may cause transient reductions of bifidobacteria.
• Pasteurized donor milk retains immune factors but fewer viable microbes.
• Skin-to-skin contact adds maternal skin and oral microbiota during feeding.
• Probiotic supplementation shows heterogeneous, strain-dependent outcomes.
• Microbial succession can be tracked by 16S and shotgun metagenomics across infancy.

Patient Guidance

• Try to start breastfeeding as early as possible after birth, whenever the medical situation allows.
• Aim for exclusive breastfeeding during the first months, while introducing solids gradually later on.
• Keep the mother’s diet rich in natural fibers and varied plant foods to support milk quality.
• Pay attention to rest and stress reduction, as maternal well-being influences lactation.
• Use antibiotics during breastfeeding only when clearly necessary and discuss protective options with your doctor.
• Include skin-to-skin contact during feedings to support natural microbial exchange.
• Avoid routine over-cleaning of the breast before feeding; normal hygiene is enough.
• If direct breastfeeding is not possible, donor human milk can be considered alongside medical advice.
• Think about probiotics only after professional consultation, choosing infant-appropriate options.
• Remember that each feeding contributes to your child’s early gut and immune development.

References

[24] Sonnenburg JL, Bäckhed F. Diet–microbiota interactions as moderators of human metabolism. Nature. 2016. Link

Review of mechanisms linking the gut microbiota to obesity and type 2 diabetes drawing on translational animal models and human studies. The microbiota emerges as a mediator of dietary impact on host metabolic status, with growing efforts to establish causal relationships in people and develop therapeutic interventions including personalised nutrition.

[39] Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016. Link

Mechanistic review of short-chain fatty acids (SCFAs) — a major class of bacterial metabolites derived from dietary fibre fermentation — as central mediators between diet, gut microbiota, and host physiology. SCFAs activate G-protein-coupled receptors, inhibit histone deacetylases, and serve as energy substrates, thereby influencing metabolic, immune, and epigenetic processes. The authors synthesize evidence implicating SCFA-mediated signalling in both health maintenance and disease pathogenesis. Provides the conceptual backbone for fibre-based and microbiome-directed therapeutic strategies.

[84] Bode, L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 2012. Link

Review of human milk oligosaccharides (HMOs), a structurally diverse glycan family abundant in and unique to human milk. Originally identified as a prebiotic bifidus factor for the infant microbiota, HMOs are now known to act as anti-adhesive antimicrobials (soluble decoy receptors preventing pathogen attachment), as well as immunomodulators and brain-development substrates. The review consolidates HMO biology and supports HMO-based interventions for infant infection prevention and microbiota development.

[144] Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007. Link

Cani and colleagues' 2007 Diabetes paper introduced the concept of 'metabolic endotoxemia' as a microbiota-driven trigger of obesity and insulin resistance. In mice, they show that a high-fat diet increases intestinal permeability and circulating lipopolysaccharide (LPS) levels, which activate TLR4-CD14 signalling and induce low-grade inflammation in adipose tissue, liver and muscle. Chronic subcutaneous LPS infusion in mice was sufficient to reproduce diet-induced obesity, insulin resistance and hepatic steatosis. CD14-knockout mice were protected. The paper established a mechanistic axis linking gut microbiota, barrier function and metabolic disease that has shaped subsequent obesity-microbiome research.